Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men

NCT02081300 is registered in ClinicalTrials.gov with Lipocine Inc. as lead sponsor.

NCT NCT02081300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02081300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Lead sponsor
Lipocine Inc.
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2014
Completion date
May 31, 2015
Enrollment
315 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

male hypogonadism